Not applicableStudy completedNCT05473741
What this trial is testing
Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
Who this might be right for
SchizophreniaSchizophrenia Relapse
Centre for Addiction and Mental Health 51
Showing 20 of 721 results